Eyenovia, Inc. (NASDAQ:EYEN) Short Interest Update

Eyenovia, Inc. (NASDAQ:EYEN) was the recipient of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 3,550,000 shares, an increase of 65.9% from the October 31st total of 2,140,000 shares. Based on an average trading volume of 4,600,000 shares, the short-interest ratio is currently 0.8 days.

Institutional Trading of Eyenovia

Several large investors have recently bought and sold shares of the company. Nations Financial Group Inc. IA ADV grew its position in Eyenovia by 24.4% in the second quarter. Nations Financial Group Inc. IA ADV now owns 50,900 shares of the company’s stock valued at $30,000 after acquiring an additional 10,000 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in Eyenovia during the second quarter valued at $26,000. Ground Swell Capital LLC bought a new stake in Eyenovia during the second quarter valued at $27,000. Financial Management Network Inc. bought a new stake in Eyenovia during the third quarter valued at $39,000. Finally, SkyView Investment Advisors LLC acquired a new stake in Eyenovia in the second quarter worth about $87,000. Institutional investors and hedge funds own 25.84% of the company’s stock.

Analyst Upgrades and Downgrades

EYEN has been the topic of a number of research reports. William Blair reissued a “market perform” rating on shares of Eyenovia in a research note on Friday, November 15th. Brookline Capital Management reissued a “hold” rating on shares of Eyenovia in a research note on Friday, November 15th. LADENBURG THALM/SH SH reissued a “neutral” rating on shares of Eyenovia in a research note on Monday, November 18th. Finally, HC Wainwright lowered shares of Eyenovia from a “buy” rating to a “neutral” rating and reduced their target price for the company from $12.00 to $2.00 in a report on Monday, November 18th.

Eyenovia Trading Up 6.6 %

Shares of EYEN stock traded up $0.01 during trading hours on Friday, hitting $0.10. 5,661,794 shares of the company were exchanged, compared to its average volume of 13,074,204. Eyenovia has a 1 year low of $0.08 and a 1 year high of $2.57. The firm has a fifty day moving average of $0.40 and a 200 day moving average of $0.66. The company has a quick ratio of 0.55, a current ratio of 0.74 and a debt-to-equity ratio of 0.58. The firm has a market cap of $8.56 million, a PE ratio of -0.14 and a beta of 1.75.

Eyenovia (NASDAQ:EYEN) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.02. Eyenovia had a negative net margin of 114,639.41% and a negative return on equity of 1,108.24%. During the same period last year, the business earned ($0.18) EPS. Analysts expect that Eyenovia will post -0.5 earnings per share for the current year.

Eyenovia Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.